NCT00003887
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +123 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Gestational Trophoblastic Tumor
Explore clinical trials studying Gestational Trophoblastic Tumor. Study availability and eligibility vary by location and protocol.
19 public trials
0 recruiting studies
Gestational Trophoblastic Tumor trial results
NCT00082654
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00109993
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
- Locations
-
- Mt. Sinai Medical Center New York, United States
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Oregon Health Sciences University Portland, Oregon, United States
NCT00410657
- Conditions
- Aberrant Motor Behavior in Dementia, Adnexal Diseases, Aggression, +109 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00010283
- Conditions
- Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00004157
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +94 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT06790706
- Conditions
- Adenocarcinoma, Anaplastic Thyroid Carcinomas, Carcinoid Tumor, +27 more
- Locations
-
- Institut de Cancerologie de l'Ouest , medical oncology department Angers, France
- Institut Bergonié, medical oncology department Bordeaux, France
- Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital Bron, France
- Centre Hospitalier Universitaire de Lille, medical oncology department Lille, France
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
NCT04562558
- Conditions
- Adenocarcinoma, Carcinoma, Choriocarcinoma, +18 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China